Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model

Modern Rheumatology

Volumn 23, Issue 4, 2013, Pages 804-810

  Ohtsubo Yoshioka, Mino ^a   Nunomura, Satoshi ^a   Kataoka, Tatsuki R ^b   Okayama, Yoshimichi ^a   Ra, Chisei ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti CII mAb induced arthritis; Fc receptor; Mast cell

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN ANTIBODY; CYTOKINE; EOSIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FC RECEPTOR; HEMATOXYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BETA CHAIN; BONE EROSION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; HISTOPATHOLOGY; JOINT SWELLING; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; SWELLING;

EID: 84880800123     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0749-z     Document Type: Article

References (28)

1. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307-10.
2. Corr M, Crain B. The role of FcγR signaling in the K/BxN serum transfer model of arthritis. J Immunol. 2002;169:6604-9.
3. Mancardi DA, Jonsson F, Iannascoli B, Khun H, Van Rooijen N, Huerre M, et al. Cutting edge: the murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis. J Immunol. 2011;186:1899-903.
4. Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003;170:4318-24.
5. Hiraoka S, Furumoto Y, Koseki H, Takagaki Y, Taniguchi M, Okumura K, et al. Fc receptor β subunit is required for full activation of mast cells through Fc receptor engagement. Int Immunol. 1999;11:199-207.
6. Bromley M, Fisher WD, Woolley DE. Mast cells at sited of cartilage erosion in the rheumatoid joint. Ann Rheum Dis. 1984;43:76-9.
7. Nigrovic PA, Lee DM. Synovial mast cells: role in acute and chronic arthritis. Immunol Rev. 2007;217:19-37.
8. Sawamukai N, Saito K, Yamaoka K, Nakayamada S, Ra C, Tanaka Y. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J Immunol. 2007;179:6479-84.
9. Juurikivi A, Sandler C, Lindstedt KA, Kovanen PT, Juutilainen T, Leskinen MJ, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis. 2005;64:1126-31.
10. Kobayashi M, Nunomura S, Gon Y, Endo D, Kishiro S, Fukunaga M, et al. Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone. J Invest Dermatol. 2010;130:725-31.
11. Zhou JS, Xing W, Friend DS, Austen KF, Katz HR. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med. 2007;204:2797-802.
12. Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, et al. Cross-talk between TLR4 and FcγReceptorIII (CD16) pathways. PLoS Pathog. 2009;5(6):e1000464.
13. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol. 2007;96:179-204.
14. Tanaka D, Kagari T, Doi H, Shimozato T. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology. 2006;119:195-202.
15. Joyce-Shaikh B, Bigler ME, Chao CC, Murphy EE, Blumenschein WM, Adamopoulos IE, et al. Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis. J Exp Med. 2010;207:579-89.
16. Kagari T, Doi H, Shimozato T. The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol. 2002;169:1459-66.
17. Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi YW, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol. 2001;159:1689-99.
18. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest. 2002;110:1419-27.
19. Theill LE, Boyle WJ, Penninger JM. RANK-L AND RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795-823.
20. Tamura T, Udagawa N, Takahashi N, Miyaura C, Tanaka S, Yamada Y, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 1993;90:11924-8.
21. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell-formation in long-term human marrow cultures by inducing IL-1 release. J Immunol. 1990;144:4226-30.
22. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337-42.
23. Dombrowicz D, Quatannens B, Papin JP, Capron A, Capron M. Expression of a functional FcεRI on rat eosinophils and macrophages. J Immunol. 2000;165:1266-71.
24. Porcherie A, Mathieu C, Peronet R, Schneider E, Claver J, Commere PH, et al. Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria. J Exp Med. 2011;208:2225-36.
25. Furumoto Y, Nunomura S, Terada T, Rivera J, Ra C. The FcεRIβ immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J Biol Chem. 2004;279:49177-87.
26. Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, et al. JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis. Proc Natl Acad Sci USA. 2010;107:22122-7.
27. Nigrovic PA, Binstadt BA, Monach PA, Johnsen A, Gurish M, Iwakura Y, et al. Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci USA. 2007;104:2325-30.
28. Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest. 2004;113(6):856-66.